Caxton Associates (New York)’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-41,622
| Closed | -$391K | – | 633 |
|
|
2022
Q4 | $391K | Sell |
41,622
-159,411
| -79% | -$1.5M | 0.03% | 272 |
|
|
2022
Q3 | $547K | Sell |
201,033
-92,615
| -32% | -$252K | 0.07% | 206 |
|
|
2022
Q2 | $849K | Buy |
293,648
+196,977
| +204% | +$570K | 0.08% | 141 |
|
|
2022
Q1 | $290K | Buy |
96,671
+78,165
| +422% | +$234K | 0.02% | 340 |
|
|
2021
Q4 | $85K | Hold |
18,506
| – | – | 0.01% | 504 |
|
|
2021
Q3 | $116K | Sell |
18,506
-13,401
| -42% | -$84K | 0.01% | 397 |
|
|
2021
Q2 | $191K | Sell |
31,907
-6,843
| -18% | -$41K | 0.02% | 401 |
|
|
2021
Q1 | $245K | Buy |
38,750
+18,849
| +95% | +$119K | 0.02% | 305 |
|
|
2020
Q4 | $112K | Buy |
+19,901
| New | +$112K | 0.01% | 108 |
|